Vident Investment Advisory’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-13,453
Closed -$1.09M 460
2023
Q2
$1.09M Sell
13,453
-5,764
-30% -$471K 0.04% 461
2023
Q1
$1.55M Sell
19,217
-2,585
-12% -$208K 0.05% 412
2022
Q4
$1.63M Sell
21,802
-41,392
-65% -$2.95M 0.06% 356
2022
Q3
$3.89M Buy
63,194
+7,817
+14% +$541K 0.13% 199
2022
Q2
$3.83M Sell
55,377
-4,854
-8% -$360K 0.11% 212
2022
Q1
$4.63M Buy
60,231
+48,570
+417% +$3.49M 0.12% 203
2021
Q4
$893K Sell
11,661
-12,198
-51% -$897K 0.02% 751
2021
Q3
$1.76M Buy
23,859
+8,864
+59% +$665K 0.05% 492
2021
Q2
$1M Buy
14,995
+4,601
+44% +$308K 0.03% 653
2021
Q1
$772K Buy
10,394
+537
+5% +$40.8K 0.03% 682
2020
Q4
$718K Buy
9,857
+740
+8% +$52.2K 0.03% 623
2020
Q3
$606K Sell
9,117
-936
-9% -$59.2K 0.03% 623
2020
Q2
$573K Buy
10,053
+2,538
+34% +$125K 0.03% 612
2020
Q1
$264K Buy
7,515
+850
+13% +$40.5K 0.02% 707
2019
Q4
$348K Sell
6,665
-280
-4% -$13.9K 0.02% 626
2019
Q3
$351K Buy
6,945
+441
+7% +$21.7K 0.03% 413
2019
Q2
$312K Buy
+6,504
New +$301K 0.03% 428
2019
Q1
Sell
-8,352
Closed -$343K 763
2018
Q4
$343K Sell
8,352
-1,719
-17% -$70.5K 0.02% 682
2018
Q3
$413K Sell
10,071
-762
-7% -$30.8K 0.02% 760
2018
Q2
$431K Sell
10,833
-1,053
-9% -$40.5K 0.02% 706
2018
Q1
$448K Buy
11,886
+1,460
+14% +$59K 0.02% 667
2017
Q4
$446K Sell
10,426
-129
-1% -$5.14K 0.02% 607
2017
Q3
$387K Buy
+10,555
New +$426K 0.02% 579
2015
Q4
Sell
-55,691
Closed -$2.18M 578
2015
Q3
$2.18M Buy
55,691
+38,457
+223% +$1.53M 0.3% 55
2015
Q2
$656K Buy
17,234
+1,731
+11% +$60.6K 0.09% 325
2015
Q1
$512K Buy
+15,503
New +$476K 0.1% 395

Other funds holding HOLX

Vident Investment Advisory's HOLX Position: Q3 2023 in Review

Vident Investment Advisory sold out of Hologic (HOLX) in Q3 2023, closing a stake of 13,453 shares — an estimated $1.09M sold.

Vident Investment Advisory first reported a position in HOLX in Q1 2015 and held it in 26 quarters. The position peaked at $4.63M in Q1 2022. 693 funds tracked by Wall St. Rank hold HOLX as of Q3 2023.

  • Vident Investment Advisory reported no remaining Hologic position as of Q3 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 13,453 Hologic shares in Q3 2023, an estimated $1.09M.
  • Vident Investment Advisory first reported a position in Hologic in Q1 2015 and held it in 26 quarters.
  • Vident Investment Advisory's Hologic position peaked at $4.63M in Q1 2022.
  • 693 funds tracked by Wall St. Rank held Hologic as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.